| GSBCX | HBLAX | GSBCX / HBLAX | |
| Total Expense Ratio | 1.57 | 0.89 | 176% |
| Annual Report Gross Expense Ratio | 1.71 | 0.89 | 192% |
| Fund Existence | 28 years | 19 years | - |
| Gain YTD | 10.562 | 10.459 | 101% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000 | 2000 | 50% |
| Min. Initial Investment IRA | 250 | 2000 | 13% |
| Net Assets | 2.67B | 11.7B | 23% |
| Annual Yield % from dividends | 3.36 | 3.23 | 104% |
| Returns for 1 year | 6.60 | 3.08 | 214% |
| Returns for 3 years | 26.79 | 15.36 | 174% |
| Returns for 5 years | 25.39 | 13.28 | 191% |
| Returns for 10 years | 69.14 | 46.09 | 150% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AMZZ | 32.47 | 0.09 | +0.27% |
| GraniteShares 2x Long AMZN Daily ETF | |||
| RAAX | 35.56 | -0.03 | -0.08% |
| VanEck Real Assets ETF | |||
| FINT | 31.18 | -0.10 | -0.31% |
| Frontier Asset Total International Equity ETF | |||
| FEBU | 27.59 | -0.13 | -0.47% |
| AllianzIM U.S. Equity Buffer15 UncFebETF | |||
| BMEZ | 15.40 | -0.19 | -1.22% |
| BlackRock Health Sciences Term Trust | |||